Psychiatric comorbidity does not predict interferon treatment completion rates in hepatitis C seropositive veterans

Journal of Clinical Gastroenterology

Volumn 41, Issue 3, 2007, Pages 322-328

  Dollarhide, Adrian W ^a,b   Loh, Catherine ^b   Leckband, Susan G ^a   Endow Eyer, Rene ^a   Robinson, Shannon ^a,b   Meyer, Jonathan M ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adverse effects; Appropriateness; Drug therapy; Hepatitis C; Interferon; Patient selection; Psychiatric

Indexed keywords

ALPHA INTERFERON; ALPHA2B INTERFERON; ANTIDEPRESSANT AGENT; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; BODY WEIGHT; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; PREDICTION; PRIORITY JOURNAL; SERODIAGNOSIS; SUBSTANCE ABUSE; UNITED STATES; VETERAN;

ANTIVIRAL AGENTS; COMORBIDITY; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS C; HUMANS; INTERFERONS; MALE; MENTAL DISORDERS; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT SELECTION; RETROSPECTIVE STUDIES; RIBAVIRIN; VETERANS;

EID: 33847420500     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mcg.0000225629.22286.96     Document Type: Article

References (30)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345:41-52.
2. Bini EJ. Hepatitis C in veterans. Curr Hepatitis Rep. 2003;2:108-115.
3. Dominitz JA, Boyko EJ, Koepsell TD, et al. Elevated prevalence of hepatitis C infection in users of United States veterans medical centers. Hepatology. 2005;41:88-96.
4. Nguyen HA, Miller AI, Dieperink E, et al. Spectrum of disease in U.S. veteran patients with hepatitis C. Am J Gastroenterol. 2002;97:1813-1820.
5. Loftis JM, Hauser P. The phenomenology and treatment of interferon-induced depression. J Affective Disord. 2004;82:175-190.
6. Dieperink E, Willenbring M, Ho SB. Neuropsychiatric symptoms associated with hepatitis C and interferon alpha: a review. Am J Psychiatry. 2000;157:867-876.
7. Goldsmith RJ, Mindrum G, Myaing M. Psychiatric assessment of patients with hepatitis C virus before initiating interferon treatment. Psychiatr Ann. 2003;33:369-376.
8. Kraus MR, Schafer A, Csef H, et al. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C. World J Gastroenterol. 2005;11:1769-1774.
9. Ho SB, Nguyen H, Tetrick LL, et al. Influence of psychiatric diagnoses on interferon-alpha treatment for chronic hepatitis C in a veteran population.[see comment]. Am J Gastroenterol. 2001;96:157-164.
10. Muir AJ, Provenzale D. A descriptive evaluation of eligibility for therapy among veterans with chronic hepatitis C virus infection. J Clin Gastroenterol. 2002;34:268-271.
11. Rosenberg SD, Goodman LA, Osher FC, et al. Prevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness. Am J Pub Health. 2001;91:31-37.
12. Meyer JM. Prevalence of hepatitis A, hepatitis B and HIV among hepatitis C seropositive state hospital patients: results from Oregon State Hospital. J Clin Psychiatry. 2003;64:540-545.
13. Dieperink E, Ho SB, Thuras P, et al. A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C.[see comment]. Psychosomatics. 2003;44:104-112.
14. Dieperink E, Ho SB, Tetrick L, et al. Suicidal ideation during interferon-alpha2b and ribavirin treatment of patients with chronic hepatitis C. Gen Hosp Psychiatry. 2004;26:237-240.
15. Schaefer M, Schmidt F, Folwaczny C, et al. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology. 2003;37:443-451.
16. Dobmeier M, Frick E, Frank S, et al. Schizophrenic psychosis: a contraindication for treatment of hepatitis C with interferon alpha? Pharmacopsychiatry. 2000;33:72-74.
17. Fultz SL, Justice AC, Butt AA, et al. Testing, referral, and treatment patterns for hepatitis C virus coinfection in a cohort of veterans with human immunodeficiency virus infection. Clin Infect Dis. 2003;36:1039-1046.
18. Kraus MR, Schafer A, Al-Taie O, et al. Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression. J Viral Hepatitis. 2005;12:96-100.
19. Schaefer M, Schwaiger M, Garkisch AS, et al. Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis C.[see comment]. J Hepatol. 2005;42:793-798.
20. Lehman CL, Cheung RC. Depression, anxiety, post-traumatic stress, and alcohol-related problems among veterans with chronic hepatitis C. Am J Gastroenterol. 2002;97:2640-2646.
21. Raison CL, Demetrashvili M, Capuron L, et al. Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs. 2005;19:105-123.
22. Tavakoli-Tabasi S, Rowan P, Abdul-Latif M, et al. Utility of a depression score to predict candidacy for hepatitis C virus therapy in veterans: a prospective longitudinal study. Alimentary Pharmacol Ther. 2005;21:235-242.
23. Wichers MC, Koek GH, Robaeys G, et al. Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes. Psychol Med. 2005;35:433-441.
24. Kraus MR, Schafer A, Faller H, et al. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy.[see comment]. J Clin Psychiatry. 2003;64:708-714.
25. Scalori A, Pozzi M, Bellia V, et al. Interferon-induced depression: prevalence and management. Dig Liver Dis. 2005;37:102-107.
26. Almasio PL. Weight-based dosing: which impact on efficacy and safety of therapy? Dig Liver Dis. 2004;36(suppl 3):s349-s353.
27. Loftis JM, Socherman RE, Howell CD, et al. Association of interferon-alpha-induced depression and improved treatment response in patients with hepatitis C. Neurosci Lett. 2004;365:87-91.
28. Cawthorne CH, Rudat KR, Burton MS, et al. Limited success of HCV antiviral therapy in United States veterans. Am J Gastroenterol. 2002;97:149-155.
29. Butt AA, Wagener M, Shakil AO, et al. Reasons for non-treatment of hepatitis C in veterans in care. J Viral Hepatitis. 2005;12:81-85.
30. Rocca LG, Yawn BP, Wollan P, et al. Management of patients with hepatitis C in a community setting: diagnosis, discussions and decisions to treat. Ann Fam Med. 2004;2:116-124.